Intense competition in vaccination against Covid-19, poor nation waiting for easy supply

Intense competition in vaccination against Covid-19, poor nation waiting for easy supply
Intense competition in vaccination against Covid-19, poor nation waiting for easy supply

The world community is plagued by the coronavirus epidemic. Attempts to provide the general public with accurate information, knowledge and awareness on how to control the epidemic or reduce the incidence of the disease have not yet paid off. That is why the rate of infection is increasing day by day. Organizations such as the World Health Organization and Johns Hopkins University are updating the corona infection and the human toll it causes on a daily basis. The new SARS coronavirus has been in the human body for almost a year, and the number of people infected with the virus worldwide has reached 71.4 million as of Saturday, and about 1.6 million people have died from the virus. There are still around 12,000 deaths from corona infection worldwide daily.
This is a terrible situation. However, the Spanish flu of 1920 killed between 20 million and 50 million people worldwide, including in Europe and the United States. Epidemics such as Ebola, HIV, AIDS, SARS, plague, and tuberculosis have also claimed many lives. But the new coronavirus, which has spread rapidly around the world for the last time, is crippling people’s daily lives as well as their economies. To control the coronavirus epidemic, the World Health Organization recommends that you wash your hands regularly with soap and water, use a sanitizer, wear a mask, and maintain a social distance of at least 2 meters when walking or visiting. Intense competition in vaccination against Covid-19.

Epidemics such as Ebola, HIV, AIDS, SARS, plague, and tuberculosis have also claimed many lives. But the new coronavirus, which has spread rapidly around the world for the last time, is crippling people’s daily lives as well as their economies. To control the coronavirus epidemic, the World Health Organization recommends that you wash your hands regularly with soap and water, use a sanitizer, wear a mask, and maintain a social distance of at least 2 meters when walking or visiting. This method is recommended considering the spread and nature of coronavirus. On the other hand, many governments have resorted to harsh measures to curb overcrowding, and this is still going on in some countries. In China, severe coronary heart disease, treatment and awareness programs were conducted during the widespread corona outbreak. But scientists say that coronaviruses can be defeated only by measures such as lockdown and social distance. Effective treatment is needed for this. But the treatment is not so easy. Scientists around the world are now exploring various drugs, vaccines and therapies to cure coronavirus. So far, these efforts have focused on building antibodies that can fight coronavirus in the body. Drugs such as hydroxychloroquine, remedivasor, azithromycin have been used, while plasma therapy has also been used. However, the World Health Organization (WHO) has said that both methods are not successful. Intense competition in vaccination against Covid-19.

In the course of this research, the world’s largest pharmaceutical companies, universities and research institutes are engaged in vaccine development. American company Moderna, US-German partnership Pfizer-Bioentech, UK’s Astrajenica-Oxford, Russia’s Sputnik V, China’s Sinofarm and Casino and India’s Serum Pharmaceuticals (Covisild) have made great strides in vaccine manufacturing. Pfizer and Modern vaccines are claimed to be up to 95 percent effective. Russia’s Sputnik, who initially claimed his vaccine was successful, lacked detailed information. Currently, the most talked about vaccine is Pfizer. The vaccine has been approved by the UK Drug Administration and is now available to the general public. In the first phase, this vaccine has been started for the elderly and health workers. The UK is the first country to recognize the Pfizer vaccine. The vaccine is expected to be approved by the US Food and Drug Administration (FDA) soon. On Thursday alone, a group of US experts affiliated with the FDA recommended that the Pfizer vaccine be allowed for emergency use. The FDA usually approves vaccinations after expert recommendation. With the onset of the second wave of corona in the United States, the number of daily infections and deaths has risen sharply, increasing the need for vaccinations. More than 9,000 people have died from corona infections in the United States over a three-day period. The death toll in the United States has risen to more than 322,000, and the number of infected people has risen to 16.3 million. The situation is similar in other countries including Brazil, India, Mexico and European countries. Considering this situation, Canada, Bahrain, Saudi Arabia and Mexico have agreed to import Pfizer vaccine, which is considered to be very effective. Mexican President Andres Manuel Lopez Obrador has announced that vaccinations will begin in Mexico in the third week of December. Intense competition in vaccination against Covid-19.

Mexico has bought about 35 million doses of Pfizer as well as Chinese casino vaccines. The European Union’s drug administration is also considering other vaccines, including Pfizer, according to the BBC. In India, the Serum Institute of India has developed a vaccine called Covisild and is conducting a final clinical trial. The company will provide about 400 million doses of vaccine to the Indian government with the permission of the Indian government, said Adar Punawala, chief executive of SERAM. According to the Ministry of Health of the United Arab Emirates (UAE), SinoVAC, developed by China’s SinoFarm, is 86 percent effective. Clinical trials of Synovac in the UAE have been conducted since last July, and the vaccine is 86 percent effective, according to data analysis. Synoform’s Synovac vaccine has arrived in Indonesia for the general public. Another 1.8 million doses will reach Indonesia by January, according to the Indonesian government. Chinese vaccines have also been sent to Turkey, Brazil and Chile. The third and final phase of clinical trials of five types of vaccines developed by four companies are currently underway in China. Sinofarm chairman Liu Jingzhen said dozens of countries were requesting to buy Sinofarm vaccines, according to CNN. The company has the capacity to produce one billion doses by the end of 2021, said Chairman Jingzhen. Compared to Pfizer and Modern, most Chinese vaccines can be kept cold and easily supplied and distributed in most developing countries. Pfizer (minus 75 degrees) and Modern (minus 20 degrees). But Chinese vaccines, India’s Covisild and AstraZeneca-Oxford vaccines can be kept at an average of 2 to 5 degrees Celsius. World leaders and engineers are urging that vaccines, which are in the final stages of construction to combat the coronavirus epidemic, should be distributed smoothly and proportionately around the world. According to the BBC, the AstraZeneca-Oxford vaccine will cost 4 per dose, Modern 33, Pfizer-Bioentech 20, Sputnik 10 and Synovac 30. The World Health Organization has stated that these vaccines should be given in two doses. The organization has also established a global access to the Covid-19 vaccine (Covax), which will take the initiative to make the corona vaccine available to all the world’s rich and poor countries at easy and affordable prices and to help poor nations. But it is not yet clear when and how the world’s poorest and most economically disadvantaged countries will be able to access these expensive vaccines.

You may also like : Trump pressures Georgia governor to reverse election results

Best site

 

Your view